By BioLabs Research · Last reviewed: October 8, 2026

Semax (ACTH 4-7 analog): a heptapeptide research compound, sequence MEHFPGP
Semax (ACTH 4-7 analog): a heptapeptide research compound, sequence MEHFPGP

Semax is a synthetic heptapeptide built as ACTH(4–7) with a C-terminal Pro-Gly-Pro (PGP) extension. The one-letter sequence is MEHFPGP: Met-Glu-His-Phe-Pro-Gly-Pro. It is not adrenocorticotropin. It is not ACTH(1–24). It is not ACTH(4–10) without the PGP tail. Catalogs that print “Semax” without the seven-letter string have not identified the reagent.

This article is an identity note for laboratory sourcing. Rodent papers exist; they are not a medicine label. This catalog’s listing is a research-use-only peptide, not a registered drug product from any jurisdiction.

HPLC laboratory bench with gloved hands holding an amber vial beside a chromatogram monitor
HPLC laboratory bench with gloved hands holding an amber vial beside a chromatogram monitor

The published heptapeptide

PubChem indexes the peptide as CID 9811102 under the title ACTH (4–7), Pro-Gly-Pro-. The computed formula is C37H51N9O10S and the molecular weight is 813.9 g/mol. The public CAS is 80714-61-0.1

FieldPublic listing (PubChem)
Common nameSemax; ACTH(4–7)-PGP
SequenceMEHFPGP / H-Met-Glu-His-Phe-Pro-Gly-Pro-OH
PubChem CID9811102
CAS80714-61-0
FormulaC37H51N9O10S
MW813.9 g/mol
Parent fragmentACTH residues 4–7 (MEHF) plus PGP

The methionine side chain is the sulfur in that formula. Oxidation of Met to sulfoxide is a known process impurity class for Met-containing peptides; it is a different mass. A COA that never mentions methionine chemistry has not finished identity work. We do not print a house oxidation percentage.

ACTH(4–7)-PGP is not ACTH

Adrenocorticotropic hormone is a 39-residue peptide in the human sequence. Residues 4–10 of ACTH are Met-Glu-His-Phe-Arg-Trp-Gly. Semax keeps 4–7 (MEHF) and replaces the rest of that span with Pro-Gly-Pro. The result is seven residues, not ten, and not thirty-nine. Calling a MEHFPGP vial “ACTH” or “ACTH(4–10)” is a mislabel.

Practical checks on a lot document:

N-terminal acetylation, C-terminal amidation, and Met(O) are three independent ways to leave the PubChem formula. Each must be named if it is what was synthesized.

Rodent literature is not a drug label

Dolotov and colleagues reported that Semax binds and increases BDNF protein levels in rat basal forebrain in a Journal of Neurochemistry study.2 That paper is rodent laboratory literature. It is cited here so a sourcing file can see the analogue named in a peer-reviewed methods context — ACTH(4–10) analogue language in the title, heptapeptide in practice — not as a clinical claim, not as a cognitive protocol, and not as a reason this catalog exists.

BioLabs Research does not sell Semax as a nootropic, a stroke medicine, or an intranasal product. If a methods section needs the Dolotov paper, it needs the paper, not a storefront paragraph.

This catalog is not the Russian registered drug

Semax has a history as a registered medicinal product in the Russian Federation under that trade name. A lyophilized research-reagent listing on an RUO catalog is not that product. It does not inherit a marketing authorization, a pharmacopoeial monograph, an approved nasal spray device, or a labeled indication. Putting the same seven letters on a vial does not make a drug.

Buyers who need a licensed medicinal product must buy a licensed medicinal product from a licensed channel. This site does not offer that channel. The RUO vial is a chemical, identified by sequence and mass.

Mass, salt, and what we will not print

The 813.9 g/mol figure is the PubChem molecular weight for the free peptide. TFA or acetate counter-ions and residual water change the mass of the powder you weigh. HPLC area% does not capture that. If the experiment is quantitative, demand net peptide content on the lot docs, as in the HPLC note. We will not invent an HPLC% or an NPC% for this SKU.

Related notes: HPLC area% vs net peptide content and How a Serious Lot Is Read.

Catalog card

The Semax catalog page lists the heptapeptide as a laboratory reagent with public identifiers and lot docs on request. Match MEHFPGP and CAS 80714-61-0 to the COA. If those lines disagree, the lot is not the listing.

The mind is not a vessel to be filled but a fire to be kindled. — Plutarch

Catalog product pack image for Semax Is ACTH(4–7)-PGP, Sequence MEHFPGP — research use only
Catalog product pack image for Semax Is ACTH(4–7)-PGP, Sequence MEHFPGP — research use only

Semax listing

Research-use-only heptapeptide MEHFPGP. Not the Russian registered drug. Sequence and CAS as public identity. Lot paper on request.

View Semax →

References

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 9811102, ACTH (4-7), Pro-Gly-Pro-. Formula C37H51N9O10S; MW 813.9 g/mol; CAS 80714-61-0. https://pubchem.ncbi.nlm.nih.gov/compound/9811102
  2. Dolotov OV, Karazeeva EP, Inozemtseva LS, et al. Semax, an analogue of adrenocorticotropin (4–10), binds specifically and increases levels of BDNF protein in rat basal forebrain. J Neurochem. 2006. PMID 16635254. Cited as rodent laboratory literature naming the analogue, not as a medicine claim. https://doi.org/10.1111/j.1471-4159.2006.03658.x

Research use only. Not for human consumption, self-administration, or therapeutic use. Laboratory reagent listing only.